Skip Navigation



QJM Advance Access published online on January 9, 2008

QJM, doi:10.1093/qjmed/hcm140
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
101/2/127    most recent
hcm140v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ross, R.
Right arrow Articles by Newton, J.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ross, R.
Right arrow Articles by Newton, J.L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the Association of Physicians. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Self-reported symptom burden; outcome in 418 patients from the Newcastle Vasovagal (Neurocardiogenic) cohort

R. Ross1, S. Parry1, M. Norton1 and J.L. Newton1,2

From the 1Falls and Syncope Service, Royal Victoria Infirmary and 2Institute of Cellular Medicine, School of Clinical Medical Sciences, University of Newcastle, UK

Address correspondence to Dr Julia L. Newton, Falls and Syncope Service/Cardiovascular Investigation Unit, University of Newcastle, Royal Victoria Infirmary, Newcastle NE1 4LP, UK. email: julia.newton{at}nuth.nhs.uk

Received 16 August 2007 and in revised form 22 October 2007


   Abstract

Background: Natural history of Vasovagal syndrome (Neurocardiogenic; NCS) is unclear.

Aim: To examine symptoms in a large cohort with head up tilt diagnosed NCS.

Methods: Questionnaires were posted to 485 patients with NCS. Data included demographic details, age at referral, presenting and on-going symptoms (syncope, dizziness and falls), symptom frequency (daily, weekly, monthly) and burden.

Results: A total of 418 questionnaires were returned (response rate 86%), 67% female. Median age at first presentation 60 (range 10–90), with men younger (54 vs. 63; P = 0.01). Seventy percent presented with syncope. Median follow-up 5 years (1–8). At follow-up 147(35%) were asymptomatic. The asymptomatic group was older (73 vs. 65; P = 0.0001) with more males (39 vs. 29%; P = 0.04). Those presenting with syncope were more likely to be symptom-free than those with dizziness (P < 0.02). Symptom frequency was greatest for those reporting dizziness at follow-up (P < 0.05). Sixty (22%) reported symptoms never preventing activities [predominantly those reporting dizziness (P = 0.04)]. Although there was a significant reduction of symptoms overall, there was a significant increase in those reporting dizziness only (P < 0.0001).

Conclusions: Of those with NCS, 35% will be symptom-free at 5 years regardless of presenting symptom or treatment received.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.